About Durin Technologies
Durin Technologies is a company based in Camden (United States) founded in 2010 by Benjamin Belinka and Robert Nagele. Durin Technologies has raised $8.05 million across 3 funding rounds from investors including Breakthrough Diagnostics. Durin Technologies offers products and services including Duritect-AD™ and Duritect-PD™. Durin Technologies operates in a competitive market with competitors including Amprion, ADx NeuroSciences, PeopleBio R&D, Cytox and ALA Diagnostics, among others.
- Headquarter Camden, United States
- Founders Benjamin Belinka, Robert Nagele
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Durin Technologies, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$8.05 M (USD)
in 3 rounds
-
Latest Funding Round
$3.5 M (USD), Debt – Conventional
Oct 26, 2023
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Durin Technologies
Durin Technologies offers a comprehensive portfolio of products and services, including Duritect-AD™ and Duritect-PD™.
Blood test for early assessment of Alzheimer's disease risk.
Blood test for early assessment of Parkinson's disease risk.
People of Durin Technologies
Unlock access to complete
Unlock access to complete
Funding Insights of Durin Technologies
Durin Technologies has successfully raised a total of $8.05M across 3 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $3.5 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Durin Technologies
Durin Technologies has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Breakthrough Diagnostics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked |
Investor details for Durin Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Durin Technologies
Investment portfolio details for Durin Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Durin Technologies
Detailed financials for Durin Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Durin Technologies Comparisons
Peer comparison for Durin Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Durin Technologies
Durin Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amprion, ADx NeuroSciences, PeopleBio R&D, Cytox and ALA Diagnostics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Assay technology for misfolded proteins in neurodegenerative disorders is developed.
|
|
| Locked | Locked | Locked |
Biomarker assays for neurodegenerative diseases are developed using custom antibodies.
|
|
| Locked | Locked | Locked |
Immunoassays are developed for early detection of neurodegenerative diseases.
|
|
| Locked | Locked | Locked |
Prognostic tests for assessing dementia risk are developed.
|
|
| Locked | Locked | Locked |
In vitro diagnostic kits for multiple sclerosis detection are developed.
|
Detailed competitors of Durin Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Durin Technologies
Complete news archive for Durin Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Durin Technologies
Durin Technologies was founded in 2010 and raised its 1st funding round 9 years after it was founded.
Durin Technologies is headquartered in Camden, United States.
Durin Technologies is a funded company, having raised a total of $8.05M across 3 funding rounds to date.
Developer of the diagnostic test for neurodegenerative diseases. The test is based on the detection of disease-specific autoantibodies as blood biomarkers associated with Alzheimers and Parkinsons disease.
Durin Technologies's top competitors include Amprion, ADx NeuroSciences and PeopleBio R&D.
Durin Technologies offers Duritect-AD™ and Duritect-PD™.
Durin Technologies has 1 investor. Key investors include Breakthrough Diagnostics.